脑膜炎疫苗项目 Meningitis Vaccine Project
流行性脑膜炎多糖疫苗 meningococcal polysaccharide vaccine
群脑膜炎球菌结合疫苗 meningococcal COniugate vaccine
脑膜炎球菌多糖疫苗 Meningococcal Poly-saccharide Vaccine
脑膜炎球菌疫苗 MENV
由世卫组织—适宜卫生技术规划伙伴关系开发的A型脑膜炎疫苗，就是为应对国家需求而进行产品开发的范例。
The development of the meningitis a vaccine by the World Health Organization [WHO] - PATH partnership is a great example of product development that is responsive to country needs.
世卫组织支持通过脑膜炎疫苗项目(适宜卫生技术规划与世卫组织之间的伙伴关系)研制这样一种疫苗。
WHO supports the development of such a vaccine through the Meningitis vaccine Project, a partnership between the Program for Appropriate Technology in Health (PATH) and WHO.
脑膜炎是相当罕见而非常严重的疾病。 由于近来年在英国大学里爆发过数起脑膜炎疾病，大学往往建议学生打脑膜炎疫苗以抵抗脑膜炎。
Meningitis is relatively rare but extremely serious and universities advise students to be immunised against meningitis C, following outbreaks on a number of UK campuses in recent years.
应用推荐